18 June 2013
Keywords: chiroscience, d3967, news, been, given, go-ahead, begin
Article | 22 January 1996
- Chiroscience has been given the go-ahead to begin Phase II clinical
studies of D3967, a singe-isomer version of ifosfamide for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 1995
17 June 2013
© 2013 thepharmaletter.com